KRAS-IN-48
KRAS-IN-48 (Compound 1-01) is a KRAS mutant inhibitor, with Kd values of 2.58 nM and 5.49 μM for KRAS-G12D and KRAS-G12V, respectively. KRAS-IN-48 can be used in the research of cancer[1].
Product Specifications
CAS Number
3074833-87-4
UNSPSC
12352005
Target
Ras
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Field of Research
Cancer
Smiles
OC=O.F[C@H](C1)CN(CCC2)[C@]12COC3=NC(N4CC5NC(CC5)C4)=C6N(C7CCC7)C(OC8=CC(O)=CC9=C8C(C#C)=C(F)C=C9)=NC6=N3.OC=O
Molecular Formula
C37H41F2N7O7
Molecular Weight
733.76
References & Citations
[1]Li X, et al. Imidazo Pyrimidine Compounds for the Inhibition of Oncogenic KRAS Mutations in Cancer Therapy. ACS Med Chem Lett. 2025 Oct 30;16 (11) :2194-2196.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
K-Ras
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
R-8005-1 1 mg
TRITC Conjugated Urtica dioica Lectin (Stinging Nettle) -UDA-
Sign In for Pricing
View Details 
BNC471940-100 1x 100 µL
Renalase (Renal Cell Marker) (RNLS/1940), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 